Cognetivity Neurosciences Ltd.
Cognetivity Neurosciences Ltd. is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA) for use in medical and commercial environments. Cognetivity’s ICA uses Artificial Intelligence and machine learning techniques to help detect the earliest signs of impairment by testing the performance of large areas of the brain, potentially allowing early diagnosis of dementia. Cognetivity aims to develop the ICA through planned clinical studies to the market in North America and Europe.
Cognetivity Neurosciences Ltd. (CGN)
Le 15 mars/March 2018
The common shares of Cognetivity Neurosciences Ltd. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the listing date.